Kangstem Biotech Co., Ltd. (KOSDAQ:217730)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,095.00
+20.00 (0.49%)
At close: Apr 28, 2026

Kangstem Biotech Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
1,9692,7675,8564,6817,542
Upgrade
Short-Term Investments
36,60015,50031,50431,00839,018
Upgrade
Trading Asset Securities
---988.8210,026
Upgrade
Cash & Short-Term Investments
38,56918,26737,36036,67856,585
Upgrade
Cash Growth
111.14%-51.11%1.86%-35.18%49.17%
Upgrade
Accounts Receivable
438.78517.34721.61,5671,225
Upgrade
Other Receivables
432.353,800411.99651.07326.35
Upgrade
Receivables
1,0715,2471,1342,2181,551
Upgrade
Inventory
814.51858.3578.26467.15763.77
Upgrade
Prepaid Expenses
381.26320330.83330.06326.96
Upgrade
Other Current Assets
2,7983,8367,9636,2136,128
Upgrade
Total Current Assets
43,63428,52847,36645,90765,355
Upgrade
Property, Plant & Equipment
17,86219,29929,57231,26534,126
Upgrade
Long-Term Investments
2,1475,6072,9501,8332,198
Upgrade
Goodwill
7,264----
Upgrade
Other Intangible Assets
9,212975.71440.121,041991.53
Upgrade
Long-Term Accounts Receivable
-00-0-0-0
Upgrade
Other Long-Term Assets
1,3751,576925.66546.68477.68
Upgrade
Total Assets
81,49355,98681,25380,592103,148
Upgrade
Accounts Payable
279.18185.84324.27406.56850.37
Upgrade
Accrued Expenses
376.14289.78483.99436.08421.19
Upgrade
Short-Term Debt
4,7553,3302,6162,5662,264
Upgrade
Current Portion of Long-Term Debt
7804005,5303,7003,500
Upgrade
Current Portion of Leases
322.88317.69808.9752.43844.37
Upgrade
Current Unearned Revenue
330330330334.05235.77
Upgrade
Other Current Liabilities
1,4622,8798,5016,0729,074
Upgrade
Total Current Liabilities
8,3057,73218,59414,26717,191
Upgrade
Long-Term Debt
2,2002,9803,3805,2305,630
Upgrade
Long-Term Leases
1,3421,4281,2741,1201,805
Upgrade
Pension & Post-Retirement Benefits
--1,507970.8913.72
Upgrade
Other Long-Term Liabilities
586.14663.316,3756,3016,323
Upgrade
Total Liabilities
12,43312,80431,13027,89031,862
Upgrade
Common Stock
47,02728,02727,96918,96918,969
Upgrade
Additional Paid-In Capital
191,691174,869174,895163,374163,374
Upgrade
Retained Earnings
-177,368-166,886-159,354-137,201-117,054
Upgrade
Comprehensive Income & Other
7,2967,1724,4694,1942,751
Upgrade
Total Common Equity
68,64543,18247,97849,33668,039
Upgrade
Minority Interest
415.2--3,494-2,110-2,070
Upgrade
Shareholders' Equity
69,06043,18250,12352,70271,286
Upgrade
Total Liabilities & Equity
81,49355,98681,25380,592103,148
Upgrade
Total Debt
9,4008,45613,60913,36914,044
Upgrade
Net Cash (Debt)
29,1699,81123,75123,30942,542
Upgrade
Net Cash Growth
197.32%-58.69%1.90%-45.21%115.13%
Upgrade
Net Cash Per Share
420.20173.97584.98614.401527.64
Upgrade
Filing Date Shares Outstanding
69.4256.0555.9437.9437.94
Upgrade
Total Common Shares Outstanding
69.4256.0555.9437.9437.94
Upgrade
Working Capital
35,33020,79628,77231,64048,165
Upgrade
Book Value Per Share
988.87770.36857.701300.441793.43
Upgrade
Tangible Book Value
52,17042,20647,53848,29567,048
Upgrade
Tangible Book Value Per Share
751.53752.96849.831273.001767.30
Upgrade
Land
3,9273,9278,2497,9847,984
Upgrade
Buildings
9,2419,24110,92010,59610,596
Upgrade
Machinery
691.99414.67595.05590.8533.4
Upgrade
Construction In Progress
176.92-310.2223.5250.96
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.